Kobayashi Pharmaceutical Co., Ltd. (TYO: 4967)

Kobayashi Pharmaceutical Ratios and Metrics

Market cap in millions JPY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 19, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	443,208	503,841	650,295	704,427	985,637	724,573
Market Cap Growth	-16.57%	-22.52%	-7.68%	-28.53%	36.03%	22.67%
Enterprise Value	392,506	409,238	545,580	602,944	888,822	648,161
Last Close Price	5962.00	6738.45	8837.09	8757.06	12107.24	8839.28
PE Ratio	43.62	24.77	32.48	35.73	51.32	37.86
Forward PE	29.03	24.52	33.46	34.40	48.90	36.13
PS Ratio	2.63	2.90	3.91	4.54	6.55	4.31
PB Ratio	2.17	2.46	3.29	3.60	5.40	4.20
P/TBV Ratio	2.29	2.75	3.52	3.85	5.81	4.27
P/FCF Ratio	-	89.91	37.88	37.56	48.82	46.12
P/OCF Ratio	-	27.44	20.38	31.42	41.09	36.07
PEG Ratio	7.89	7.89	7.89	7.89	7.89	7.85
EV/Sales Ratio	2.33	2.36	3.28	3.88	5.91	3.86
EV/EBITDA Ratio	13.18	12.92	17.12	19.58	29.71	21.37
EV/EBIT Ratio	16.91	15.97	20.58	23.23	34.44	24.73
EV/FCF Ratio	-	73.03	31.78	32.15	44.02	41.26
Debt / Equity Ratio	0.00	0.00	0.00	0.00	0.00	0.01
Debt / EBITDA Ratio	0.03	0.03	0.02	0.02	0.02	0.03
Debt / FCF Ratio	-	0.18	0.05	0.03	0.03	0.06
Asset Turnover	0.65	0.66	0.65	0.63	0.64	0.72
Inventory Turnover	2.69	3.88	4.51	4.55	4.47	4.50
Quick Ratio	2.30	2.37	2.94	3.24	2.94	2.72
Current Ratio	3.20	2.82	3.34	3.59	3.28	3.05
Return on Equity (ROE)	4.86%	10.10%	10.18%	10.43%	10.81%	11.29%
Return on Assets (ROA)	5.56%	6.12%	6.52%	6.61%	6.84%	7.05%
Return on Capital (ROIC)	6.89%	7.92%	8.39%	8.55%	9.04%	9.61%
Earnings Yield	2.29%	4.04%	3.08%	2.80%	1.95%	2.64%
FCF Yield	1.11%	2.64%	2.66%	2.05%	2.17%
Dividend Yield	1.69%	1.50%	1.02%	0.95%	0.64%	0.83%
Payout Ratio	0.00%	35.51%	32.51%	31.71%	30.12%	27.86%
Buyback Yield / Dilution	2.24%	1.67%	1.27%	0.05%	0.32%	0.82%
Total Shareholder Return	3.93%	3.17%	2.29%	1.00%	0.96%	1.65%

Source: S&P Capital IQ. Standard template. Financial Sources.